Díez-Pérez A
*, Adachi JD, Adami S, Anderson Jr FA, Boonen S, Chapurlat RD, Compston JE, Cooper C, Gehlbach S, Greenspan SL, Hooven FH, LaCroix AZ, Nieves J, Netelenbos JC, Pfeilschifter J, Rossini M, Roux C, Saag KG, Silverman S, Siris ES, Wyman A, Rushton-Smith SK, Watts NB, for the GLOW Investigators.
Risk factors for treatment failure with antiosteoporosis medication: The global longitudinal study of osteoporosis in women (GLOW). J Bone Miner Res 2014; 29(1): 260-267.